FIELD: biotechnology.
SUBSTANCE: group of inventions including a compound, a pharmaceutical composition for the treatment of a disease or condition mediated by α 1-antitrypsin, including the above compound, a method of treating a disease or condition mediated by α 1-antitrypsin, the use of a compound or pharmaceutical composition for the treatment of a disease or condition mediated by α 1-antitrypsin, and the use of the compound or pharmaceutical composition in the manufacture of a medicinal product for use in the treatment of a disease or condition mediated by alpha 1-antitrypsin.
EFFECT: invention expands the range of means for treating a disease or condition mediated byα 1-antitrypsin.
31 cl, 3 dwg, 6 tbl, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| RECOMBINANT pMHC MOLECULES OF CLASS II | 2017 |
|
RU2777115C2 |
| ENGINEERED MULTI-SPECIFIC ANTIBODIES AND OTHER MULTIMERIC PROTEINS WITH ASYMMETRIC MUTATIONS IN THE CH2-CH3 REGION | 2018 |
|
RU2804031C2 |
| CONJUGATES OF BINDER AND ACTIVE SUBSTANCE (ADC) HAVING ENZYMATICALLY CLEAVABLE GROUPS | 2017 |
|
RU2761390C2 |
| FUSED SERPIN POLYPEPTIDES AND METHODS FOR USE THEREOF | 2019 |
|
RU2728861C1 |
| TETRAVALENT SYMMETRICAL BISPECIFIC ANTIBODIES | 2019 |
|
RU2807346C2 |
| FUSED SERPIN POLYPEPTIDES AND METHODS FOR USE THEREOF | 2012 |
|
RU2698655C2 |
| POLYPEPTIDE LINKER FOR PRODUCTION OF MULTI-SPECIFIC ANTIBODIES | 2018 |
|
RU2776302C2 |
| PEPTIDE, PHARMACEUTICAL COMPOSITION (VERSIONS) AND MEDICATION | 2007 |
|
RU2492183C2 |
| TREATMENT OF DISEASES BY MEANS OF EXPRESSION OF ENZYME WITH DEOXYRIBONUCLEASE (DNase) ACTIVITY IN LIVER | 2019 |
|
RU2773691C2 |
| COMPOSITIONS AND METHODS FOR IMMUNOTHERAPY AGAINST CD20 | 2017 |
|
RU2782699C2 |
